Cargando…
Application of recombinant antibodies for treatment of Clostridioides difficile infection: Current status and future perspective
Clostridioides difficile (C. difficile), known as the major cause of antibiotic-associated diarrhea, is regarded as one of the most common healthcare-associated bacterial infections worldwide. Due to the emergence of hypervirulent strains, development of new therapeutic methods for C. difficile infe...
Autores principales: | Raeisi, Hamideh, Azimirad, Masoumeh, Nabavi-Rad, Ali, Asadzadeh Aghdaei, Hamid, Yadegar, Abbas, Zali, Mohammad Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445313/ https://www.ncbi.nlm.nih.gov/pubmed/36081500 http://dx.doi.org/10.3389/fimmu.2022.972930 |
Ejemplares similares
-
Rapid-format recombinant antibody-based methods for the diagnosis of Clostridioides difficile infection: Recent advances and perspectives
por: Raeisi, Hamideh, et al.
Publicado: (2022) -
Development and characterization of phage display-derived anti-toxin antibodies neutralizing TcdA and TcdB of Clostridioides difficile
por: Raeisi, Hamideh, et al.
Publicado: (2023) -
Emerging applications of phage therapy and fecal virome transplantation for treatment of Clostridioides difficile infection: challenges and perspectives
por: Raeisi, Hamideh, et al.
Publicado: (2023) -
How Does COVID-19 Pandemic Impact on Incidence of Clostridioides difficile Infection and Exacerbation of Its Gastrointestinal Symptoms?
por: Azimirad, Masoumeh, et al.
Publicado: (2021) -
Curcumin and capsaicin regulate apoptosis and alleviate intestinal inflammation induced by Clostridioides difficile in vitro
por: Azimirad, Masoumeh, et al.
Publicado: (2022)